CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)
Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%
Cvs Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cvs Health's operating income for the twelve months ending Jun 30, 2026 was $8.29B, down 7.4% year over year. For fiscal 2025 it was $4.66B, down 45.3% from the year before. Over ten years it grew -6.9% a year on average. The highest annual figure on record is $13.91B in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.66B | -45.3% |
| FY2024 | Dec 31, 2024 | $8.52B | -38.0% |
| FY2023 | Dec 31, 2023 | $13.74B | +72.8% |
| FY2022 | Dec 31, 2022 | $7.95B | -40.2% |
| FY2021 | Dec 31, 2021 | $13.31B | -4.3% |
| FY2020 | Dec 31, 2020 | $13.91B | +16.1% |
| FY2019 | Dec 31, 2019 | $11.99B | +198.1% |
| FY2018 | Dec 31, 2018 | $4.02B | -57.8% |
| FY2017 | Dec 31, 2017 | $9.54B | -8.2% |
| FY2016 | Dec 31, 2016 | $10.39B | +9.6% |
| FY2015 | Dec 31, 2015 | $9.48B | +7.7% |
| FY2014 | Dec 31, 2014 | $8.80B | +9.5% |
| FY2013 | Dec 31, 2013 | $8.04B | +11.5% |
| FY2012 | Dec 31, 2012 | $7.21B | +13.9% |
| FY2011 | Dec 31, 2011 | $6.33B | +3.2% |
| FY2010 | Dec 31, 2010 | $6.14B | -4.5% |
| FY2009 | Dec 31, 2009 | $6.43B | +6.3% |
| FY2008 | Dec 31, 2008 | $6.05B | +26.1% |
| FY2007 | Dec 29, 2007 | $4.79B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.70B | +97.5% |
| Q1 FY2026 | Mar 31, 2026 | $4.68B | +38.7% |
| Q4 FY2025 | Dec 31, 2025 | $2.11B | -10.8% |
| Q3 FY2025 | Sep 30, 2025 | -$3.21B | -485.5% |
| Q2 FY2025 | Jun 30, 2025 | $2.38B | -21.8% |
| Q1 FY2025 | Mar 31, 2025 | $3.37B | +48.6% |
| Q4 FY2024 | Dec 31, 2024 | $2.37B | -29.8% |
| Q3 FY2024 | Sep 30, 2024 | $832.00M | -77.5% |
| Q2 FY2024 | Jun 30, 2024 | $3.05B | -5.8% |
| Q1 FY2024 | Mar 31, 2024 | $2.27B | -34.1% |
| Q4 FY2023 | Dec 31, 2023 | $3.37B | -7.8% |
| Q3 FY2023 | Sep 30, 2023 | $3.69B | – |
| Q2 FY2023 | Jun 30, 2023 | $3.23B | -30.7% |
| Q1 FY2023 | Mar 31, 2023 | $3.45B | -2.8% |
| Q4 FY2022 | Dec 31, 2022 | $3.66B | +56.0% |
| Q3 FY2022 | Sep 30, 2022 | -$3.92B | -228.0% |
| Q2 FY2022 | Jun 30, 2022 | $4.67B | +7.9% |
| Q1 FY2022 | Mar 31, 2022 | $3.55B | -0.9% |
| Q4 FY2021 | Dec 31, 2021 | $2.35B | -7.1% |
| Q3 FY2021 | Sep 30, 2021 | $3.06B | -5.8% |
| Q2 FY2021 | Jun 30, 2021 | $4.33B | -7.6% |
| Q1 FY2021 | Mar 31, 2021 | $3.58B | +3.4% |
| Q4 FY2020 | Dec 31, 2020 | $2.52B | -16.9% |
| Q3 FY2020 | Sep 30, 2020 | $3.25B | +11.0% |
| Q2 FY2020 | Jun 30, 2020 | $4.68B | +40.5% |
| Q1 FY2020 | Mar 31, 2020 | $3.46B | +28.6% |
| Q4 FY2019 | Dec 31, 2019 | $3.04B | +268.6% |
| Q3 FY2019 | Sep 30, 2019 | $2.93B | +13.8% |
| Q2 FY2019 | Jun 30, 2019 | $3.33B | – |
| Q1 FY2019 | Mar 31, 2019 | $2.69B | +34.8% |
| Q4 FY2018 | Dec 31, 2018 | $824.00M | -73.5% |
| Q3 FY2018 | Sep 30, 2018 | $2.57B | +2.8% |
| Q2 FY2018 | Jun 30, 2018 | -$1.37B | -164.7% |
| Q1 FY2018 | Mar 31, 2018 | $2.00B | +11.0% |
| Q4 FY2017 | Dec 31, 2017 | $3.11B | +3.8% |
| Q3 FY2017 | Sep 30, 2017 | $2.50B | -11.3% |
| Q2 FY2017 | Jun 30, 2017 | $2.12B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.80B | – |
| Q4 FY2016 | Dec 31, 2016 | $3.00B | – |
| Q3 FY2016 | Sep 30, 2016 | $2.82B | – |
See a number that looks wrong?